study of neratinib for patients with her2-positive breast cancer with brain metastases
Published 5 years ago • 1.6K plays • Length 5:21Download video MP4
Download video MP3
Similar videos
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
4:14
study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
2:46
program for patients with breast cancer brain metastases | dana-farber cancer institute
-
1:02
dr. freedman on neratinib plus capecitabine for cns disease from her2-positive breast cancer
-
1:31
results for neratinib plus capecitabine in her2 breast cancer brain metastases
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
14:18
a new treatment for breast cancer patients with brain metastases: an interview with dr. nancy lin
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
0:49
systemic therapies shown to be effective in her2-positive breast cancer
-
1:21
esmo24: nancy lin, md metastatic brain cancer | dana-farber cancer institute
-
2:25
what is her2-positive breast cancer? | dana-farber cancer institute